Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,242,493
  • Shares Outstanding, K 50,699
  • Annual Sales, $ 988,480 K
  • Annual Income, $ 76,530 K
  • 60-Month Beta 0.60
  • Price/Sales 4.48
  • Price/Cash Flow 15.60
  • Price/Book 7.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.50
  • Number of Estimates 4
  • High Estimate 0.59
  • Low Estimate 0.45
  • Prior Year 0.87
  • Growth Rate Est. (year over year) -42.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.40 unch
on 09/18/20
94.79 -13.07%
on 09/10/20
-5.22 (-5.96%)
since 08/18/20
3-Month
74.48 +10.63%
on 08/06/20
94.79 -13.07%
on 09/10/20
-3.38 (-3.94%)
since 06/18/20
52-Week
63.41 +29.95%
on 03/18/20
132.73 -37.92%
on 09/20/19
-45.39 (-35.52%)
since 09/18/19

Most Recent Stories

More News
Haemonetics To Present At The 18th Annual Morgan Stanley Global Healthcare Conference

, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 18 Annual Morgan Stanley Virtual Global Healthcare Conference on Tuesday, Sept....

MS : 50.49 (+0.48%)
HAE : 81.72 (-2.34%)
SmarTrend Watching for Potential Pullback in Shares of Haemonetics Corp After 2.58% Gain

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $91.51 to a high of $94.30. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of...

HAE : 81.72 (-2.34%)
Haemonetics (HAE) Up 18.4% Since Last Earnings Report: Can It Continue?

Haemonetics (HAE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HAE : 81.72 (-2.34%)
Ortho Announces Board of Director Appointments

Noted Diagnostic Industry Veteran David B. Perez Joins as an Independent Director Chris Smith Appointed Chairman of the Board, in addition to current CEO role , /PRNewswire/ -- Ortho Clinical Diagnostics,...

HAE : 81.72 (-2.34%)
Haemonetics Corp Rises 2.42% on Heavy Volume: Watch For Potential Pullback

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $88.07 to a high of $90.79. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of...

HAE : 81.72 (-2.34%)
Haemonetics Corp Falls 3.74% on Heavy Volume: Watch For Potential Rebound

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $82.75 to a high of $87.57. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $83.11...

HAE : 81.72 (-2.34%)
Look for Shares of Haemonetics Corp to Potentially Pullback after Yesterday's 4.30% Rise

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $80.14 to a high of $84.04. Yesterday, the shares gained 4.3%, which took the trading range above the 3-day high of...

HAE : 81.72 (-2.34%)
Haemonetics Clinical Study Results On A New, Personalized Approach To Plasma Collection To Be Presented At 2020 AABB Annual Meeting

, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, today announced it will...

HAE : 81.72 (-2.34%)
Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Down

Haemonetics' (HAE) first-quarter fiscal 2021 results reflect impressive performance by Blood Center segment despite dismal overall performance during the coronavirus-led crisis.

HOLX : 62.63 (-0.95%)
HAE : 81.72 (-2.34%)
TMO : 428.32 (-1.06%)
WST : 276.62 (+0.60%)
Watch for Haemonetics Corp to Potentially Rebound After Falling 9.46% Yesterday

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $76.85 to a high of $86.37. Yesterday, the shares fell 9.5%, which took the trading range below the 3-day low of $86.59...

HAE : 81.72 (-2.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade HAE with:

Business Summary

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through...

See More

Key Turning Points

2nd Resistance Point 87.73
1st Resistance Point 85.70
Last Price 81.72
1st Support Level 82.60
2nd Support Level 81.53

See More

52-Week High 132.73
Fibonacci 61.8% 106.25
Fibonacci 50% 98.07
Fibonacci 38.2% 89.89
Last Price 81.72
52-Week Low 63.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar